Human Health Effects of Drinking Water Exposures to Per- and Polyfluoroalkyl Substances (PFAS) at Pease International Tradeport, Portsmouth, NH (The Pease Study)
ICR 201909-0923-001
OMB: 0923-0061
Federal Form Document
⚠️ Notice: This information collection may be outdated. More recent filings for OMB 0923-0061 can be found here:
Human Health Effects of
Drinking Water Exposures to Per- and Polyfluoroalkyl Substances
(PFAS) at Pease International Tradeport, Portsmouth, NH (The Pease
Study)
No
material or nonsubstantive change to a currently approved
collection
Previous terms
continue: Consistent with the Supporting Statement, the statistical
power and sampling frame of this proof of concept study limits
ATSDR’s ability to detect moderate differences (between exposed and
nonexposed individuals) in many of health conditions queried in
this collection. Approval for the collection of information about
conditions for which there is not adequate statistical power is
provided specifically for the purposes of evaluating the study
procedures, methods, and hypotheses for a future multi-site study.
Approval is provided contingent upon a commitment to investigate
other contributing environmental factors when associations or
trends are observed between PFAS exposure and health conditions.
Approval is also provided contingent upon a commitment to work with
the National Center for Health Statistics on disclosure review
procedures and include a member of NCHS’s disclosure review board
for NHANES on the PEAS disclosure review board.
Inventory as of this Action
Requested
Previously Approved
08/31/2022
08/31/2022
08/31/2022
5,852
0
5,852
1,454
0
1,454
42,227
0
42,227
The Pease Study will serve as a
proof-of-concept model for a multi-site study of PFAS health
effects. The existence of a large body of state and local
environmental monitoring and population blood testing data makes
the Pease community in Portsmouth, NH particularly suitable as
ATSDR’s initial PFAS research study site. The main goals of the
research study are to: 1) evaluate the study procedures and methods
to identify any changes to the design or protocol that need to be
made before embarking on a multi-site study; and 2) examine
associations between a limited number of health outcomes for which
statistical power is adequate and measured and historically
reconstructed serum levels of PFAS (e.g., lipids, renal function
and kidney disease, thyroid hormones and disease, liver function
and disease, glycemic parameters and diabetes, as well as immune
response and function in both children and adults). Request for
change to retain leftover blood with participant consent.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.